Li et al (2012) conducted a study with 78 patients with colorectal adenocarcinoma and reported a correlation between KRAS mutation status, liver metastases (P < 0.05), and poor tumor differentiation (P < 0.05). This evidence concerns the gene KRAS and colorectal adenocarcinoma.